A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. [electronic resource]
Producer: 20110512Description: 1873-81 p. digitalISSN:- 1538-3598
- Adult
- Algorithms
- Anthracyclines -- therapeutic use
- Antineoplastic Agents, Hormonal -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biopsy, Needle
- Breast Neoplasms -- drug therapy
- Bridged-Ring Compounds -- therapeutic use
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Forecasting
- Gene Expression Profiling
- Genes, Neoplasm -- genetics
- Genes, erbB-2
- Genomics
- Humans
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local
- Oligonucleotide Array Sequence Analysis
- Predictive Value of Tests
- Prognosis
- Prospective Studies
- Receptors, Estrogen -- analysis
- Risk
- Taxoids -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.